Morin, Jr.; John Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Morin, Jr.; John Michael.The latest application filed is for "novel spla2 inhibitors".
- Morin, Jr.; John Michael - Brownsburg IN
| Patent | Date |
|---|---|
| Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes Grant 7,229,987 - Ammenn , et al. June 12, 2 | 2007-06-12 |
| Cyclohept[b]indole derivatives Grant 7,109,231 - Kinnick , et al. September 19, 2 | 2006-09-19 |
| sPLA.sub.2 inhibitors Grant 6,992,100 - Beight , et al. January 31, 2 | 2006-01-31 |
| Spla2 inhibitors Grant 6,916,840 - Beight , et al. July 12, 2 | 2005-07-12 |
| sPLA2 inhibitors Grant 6,872,743 - Beight , et al. March 29, 2 | 2005-03-29 |
| Novel spla2 inhibitors App 20040092543 - Beight, Douglas Wade ; et al. | 2004-05-13 |
| sPLA2 inhibitors Grant 6,730,694 - Beight , et al. May 4, 2 | 2004-05-04 |
| Substituted tricyclics Grant 6,713,645 - Bach , et al. March 30, 2 | 2004-03-30 |
| Glycoprotein IIB/IIIA antagonists Grant 6,472,405 - Fisher , et al. October 29, 2 | 2002-10-29 |
| Substituted tricyclics Grant 6,177,440 - Bach , et al. January 23, 2 | 2001-01-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 